We have improved the traditional specialty pharmaceutical business model and have a unique and sophisticated approach to evaluating and selecting potential product candidates. We choose to focus on large markets with life cycle management opportunities and find niche sub-segments within these markets with low promotional noise for marketed products. We seek to purchase rights to certain products with potential as well as existing, well-known brand names or trademarks in the space. We believe a life cycle management drug with a well-known brand name or trademark operating in a segment without intense competition provides a strong foundation to execute a growth strategy in the specialty pharmaceutical industry. A final component in our strategy that differentiates us from traditional specialty pharmaceutical models includes partnering with leading domestic and international pharmaceutical companies to develop and promote products in the U.S. markets.

You may contact us at contact@cornerstonebiopharma.com.